NCT00394745 Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome Status COMPLETED Phase PHASE3
NCT00394394 Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril Status COMPLETED Phase PHASE2
NCT00393419 Federal Study of Adherence to Medications in the Elderly (FAME) Status COMPLETED Phase NA
NCT00392262 A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients Status COMPLETED Phase PHASE3
NCT00389779 DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension Status COMPLETED Phase PHASE3
NCT00389675 DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension Status TERMINATED Phase PHASE3
NCT00389519 A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents Status TERMINATED Phase PHASE3
NCT00389168 Irbesartan and Atenolol in Hypertensive Heart Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00387517 Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension Status COMPLETED Phase PHASE3
NCT00387166 Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women Status COMPLETED Phase N/A
NCT00386607 A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. Status COMPLETED Phase PHASE3
NCT00386139 A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients Status COMPLETED Phase PHASE3
NCT00385931 Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin Status COMPLETED Phase PHASE3
NCT00384241 Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure Status COMPLETED Phase N/A
NCT00383929 Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg Status COMPLETED Phase PHASE3
NCT00382564 Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease Status COMPLETED Phase N/A